Cytidine Deaminase Enzymatic Activity Is a Prognostic Biomarker in Gemcitabine/Platinum-Treated Advanced Non-Small-Cell Lung Cancer: A Prospective Validation Study

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0307-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pharmacokinetics of Gemcitabine in Non-Small-Cell Lung Cancer Patients: Impact of the 79A>C Cytidine Deaminase Polymorphism

European Journal of Clinical Pharmacology
MedicinePharmacology
2010English

The Hemoglobin Level as a Prognostic Factor in Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Cis-Platinum

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2012English

BAP1 Is a Good Prognostic Factor in Advanced Non-Small Cell Lung Cancer

Clinical and Investigative Medicine
Medicine
2012English

CPSF3 Is a Promising Prognostic Biomarker and Predicts Recurrence of Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer

Cancer Informatics
Cancer ResearchOncology
2019English

Paclitaxel Alters the Expression and Specific Activity of Deoxycytidine Kinase and Cytidine Deaminase in Non-Small Cell Lung Cancer Cell Lines

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2009English

Gemcitabine Plus Vinorelbine in Advanced Non-Small Cell Lung Cancer: A Phase II Study of Three Different Doses

British Journal of Cancer
Cancer ResearchOncology
2000English

Epithelial-Specific Methylation Marker: A Potential Plasma Biomarker in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

162P: Molecular Markers in Advanced Non Small Cell Lung Cancer Patients Receiving Gemcitabine & Cisplatin

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy